|
Volumn 9, Issue 8, 2002, Pages 893-898
|
Neoadjuvant chemotherapy in non-small cell lung cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
BRYOSTATIN;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
ETOPOSIDE;
FLUOROURACIL;
GEFITINIB;
GEMCITABINE;
IFOSFAMIDE;
MARIMASTAT;
MATRIX METALLOPROTEINASE INHIBITOR;
MITOMYCIN;
PACLITAXEL;
PROTEIN P53;
TIRAPAZAMINE;
TRASTUZUMAB;
VASCULOTROPIN;
VINBLASTINE;
VINCA ALKALOID;
VINDESINE;
ADVANCED CANCER;
CANCER RECURRENCE;
CANCER RESEARCH;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG RESPONSE;
GRANULOCYTOPENIA;
HIGH RISK PATIENT;
HUMAN;
LUNG NON SMALL CELL CANCER;
MOLECULAR BIOLOGY;
PREOPERATIVE CARE;
REVIEW;
SYSTEMIC DISEASE;
VIRAL GENE DELIVERY SYSTEM;
|
EID: 0036250226
PISSN: 09298673
EISSN: None
Source Type: Journal
DOI: 10.2174/0929867024606768 Document Type: Review |
Times cited : (8)
|
References (29)
|